Comparison between conventional blind embryo transfer and embryo transfer based on previously measured uterine length

Comparison between the effect of conventional embryo transfer and embryo transfer based on previously measured uterine length on pregnancy and implantation rates in fresh ART cycles in IVF ward of Taleghani Hospital

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014032512494N1

Enrollment

160

Registered

2014-03-25

Start date

2009-12-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Not have

Interventions

Intervention 1: In intervention group: The type of stimulatory cycle (Agonist or Antagonist) were selected based on the age of woman and other factores. (agonist

Superfact: mination Hoechst, Frankfurt, Germany)antagonist

cetrotide,EMDSerono,inc).Ovarian stimulation was done using r-FSH (GonalF

Serono,Laboratories.Ltd,Geneva,Switzerland),Merional or Fostimon ( IBSA,Switzerland), single or in combination. When the leading follicles reachd 17-18mm in diameter HCG 10,000 unit (IBSA,Switzerland)

cetrotide,EMDSerono,inc).Ovarian stimulation is done using r-FSH (GonalF

Treatment - Drugs

In intervention group: The type of stimulatory cycle (Agonist or Antagonist) were selected based on the age of woman and other factores. (agonist

Superfact: mination Hoechst, Frankfurt, Germany)antagonist

Serono,Laboratories.Ltd,Geneva,Switzerland),Merional or Fostimon ( IBSA,Switzerland), single or in combination. When the leading follicles reachd 17-18mm in diameter HCG 10,000 unit (IBSA,Switzerland

In control group: The type of stimulatory cycle (Agonist or Antagonist) are selected based on the age of woman and other factores. (agonist

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All the patients who underwent ICSI in this period of time in our center that reached the embryo transfer step, were enrolled in the study. Exclusion criteria : Egg donation cycles; embryo donation cycles; frozen embryo transfers were excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: 2wks after embryo transfer. Method of measurement: Serum B-HCG.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Vaginal sonography.;Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Vaginal sonography.;Implantation rate. Timepoint: End of the study. Method of measurement: Number of gestational sacs at vaginal sonography divided by total number of transfered embryos.	—

Measure

Time frame

Chemical pregnancy. Timepoint: 2wks after embryo transfer. Method of measurement: Serum B-HCG.;Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Vaginal sonography.;Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Vaginal sonography.;Implantation rate. Timepoint: End of the study. Method of measurement: Number of gestational sacs at vaginal sonography divided by total number of transfered embryos.

—

Secondary

Measure	Time frame
Abortion rate. Timepoint: First trimester. Method of measurement: Clinical sign and vaginal ultrasound.;Ectopic pregnancy rate. Timepoint: First trimester. Method of measurement: Clinical sign and vaginal ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Nasrin Saharkhiz

Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science

saharkhiz1377@yahoo.com+98 21 2243 2558

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026